These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7783344)

  • 41. Preclinical and clinical pharmacology of antisense oligonucleotides.
    Marcusson EG; Yacyshyn BR; Shanahan WR; Dean NM
    Mol Biotechnol; 1999 Aug; 12(1):1-11. PubMed ID: 10554769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antisense anticancer oligonucleotide therapeutics.
    Wang H; Prasad G; Buolamwini JK; Zhang R
    Curr Cancer Drug Targets; 2001 Nov; 1(3):177-96. PubMed ID: 12188878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antisense oligonucleotides in cancer.
    Castanotto D; Stein CA
    Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does antisense make sense in dermatology?
    van Erp PE; Wingens M
    Acta Derm Venereol; 2001; 81(6):385-91. PubMed ID: 11859937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective anti-gene therapy for cancer: principles and prospects.
    Cohen JS
    Tohoku J Exp Med; 1992 Oct; 168(2):351-9. PubMed ID: 1306320
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent status of the antisense oligonucleotide approaches in oncology.
    Ma L; Calvo F
    Fundam Clin Pharmacol; 1996; 10(2):97-115. PubMed ID: 8737953
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Manipulating expression of endogenous oncogenic proteins using an antisense oligonucleotide approach in prostate cancer cells.
    Wu D; Wescott GG; Terrian DM
    Methods Mol Biol; 2003; 218():143-53. PubMed ID: 12616719
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisense oligonucleotides, microRNAs, and antibodies.
    Dávalos A; Chroni A
    Handb Exp Pharmacol; 2015; 224():649-89. PubMed ID: 25523006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oligonucleotides as therapeutic agents.
    Cohen JS
    Pharmacol Ther; 1991 Nov; 52(2):211-25. PubMed ID: 1818337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs and their antagonists as novel therapeutics.
    Shomron N
    Eur J Cancer; 2009 Sep; 45 Suppl 1():388-90. PubMed ID: 19775642
    [No Abstract]   [Full Text] [Related]  

  • 51. Clinical trials of a new class of therapeutic agents: antisense oligonucleotides.
    Galderisi U; Cipollaro M; Cascino A
    Expert Opin Emerg Drugs; 2001 Apr; 6(1):69-79. PubMed ID: 15989497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospects for gene-directed therapy with antisense oligodeoxynucleotides.
    Calabretta B; Skorski T; Szczylik C; Zon G
    Cancer Treat Rev; 1993 Apr; 19(2):169-79. PubMed ID: 8481928
    [No Abstract]   [Full Text] [Related]  

  • 53. The mathematical framework essential for magneto-therapy in the treatment of genomic and associated disorders, including cancer, AIDS, and CNS regeneration.
    Jacobson JI
    Panminerva Med; 1989; 31(1):1-7. PubMed ID: 2726282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene therapy for cancer.
    Kipps TJ
    J Hematother; 1993; 2(3):367-72. PubMed ID: 7921998
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antisense therapy: therapeutic magic bullet or theoretical dream?
    Turner C
    Clin Oncol (R Coll Radiol); 1997; 9(1):54-8. PubMed ID: 9039815
    [No Abstract]   [Full Text] [Related]  

  • 56. Marilyn Finkler Symposium on Future Trends in Research on AIDS, Cancer and Therapies. Israel, July 1-2, 1987. Proceedings.
    Nat Immun Cell Growth Regul; 1988; 7(3):128-92. PubMed ID: 3173368
    [No Abstract]   [Full Text] [Related]  

  • 57. Hydrogen peroxide-triggered gene silencing in mammalian cells through boronated antisense oligonucleotides.
    Mori S; Morihiro K; Okuda T; Kasahara Y; Obika S
    Chem Sci; 2018 Feb; 9(5):1112-1118. PubMed ID: 29629168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. European School of Oncology Task Force Papers: gene therapy--a future in cancer management? Antisense therapy for malignant disease.
    O'Brien SG; Kirkland MA; Goldman JM
    Eur J Cancer; 1994; 30A(8):1160-4. PubMed ID: 7654449
    [No Abstract]   [Full Text] [Related]  

  • 59. Prospects for a systemic therapy of cancer.
    BRUES AM
    Natl Cancer Inst Monogr; 1960 Mar; 2():179-87. PubMed ID: 13805192
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prospects for antisense therapy].
    Maekawa T
    Rinsho Ketsueki; 1995 May; 36(5):410-8. PubMed ID: 7783344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.